BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33197439)

  • 1. Expression and role of MIG/CXCR3 axis in mantle cell lymphoma.
    Zhu MX; Wan WL; Hong Y; Wang YF; Dong F; Jing HM
    Exp Cell Res; 2020 Dec; 397(2):112365. PubMed ID: 33197439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma.
    Li Z; Liu J; Li L; Shao S; Wu J; Bian L; He Y
    Oncol Rep; 2018 Mar; 39(3):1356-1368. PubMed ID: 29286143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIG Th1 chemokine in Vitiligo.
    Elia G
    Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
    Neo SY; Lundqvist A
    Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.
    Trentin L; Agostini C; Facco M; Piazza F; Perin A; Siviero M; Gurrieri C; Galvan S; Adami F; Zambello R; Semenzato G
    J Clin Invest; 1999 Jul; 104(1):115-21. PubMed ID: 10393705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism.
    Ohshima K; Suefuji H; Karube K; Hamasaki M; Hatano B; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kikuchi M
    Leuk Lymphoma; 2003 Feb; 44(2):329-36. PubMed ID: 12688353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma.
    Jinquan T; Quan S; Jacobi HH; Jing C; Millner A; Jensen B; Madsen HO; Ryder LP; Svejgaard A; Malling HJ; Skov PS; Poulsen LK
    Blood; 2000 Aug; 96(4):1230-8. PubMed ID: 10942362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis and the Th1 chemokine MIG.
    Ragusa F
    Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes and MIG.
    Gonnella D
    Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
    Jones D; Benjamin RJ; Shahsafaei A; Dorfman DM
    Blood; 2000 Jan; 95(2):627-32. PubMed ID: 10627472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.
    Bolomsky A; Schreder M; Hübl W; Zojer N; Hilbe W; Ludwig H
    Leuk Lymphoma; 2016 Nov; 57(11):2516-25. PubMed ID: 26999330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MIG Chemokine in Inflammatory Myopathies.
    Paparo SR
    Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatomyositis and MIG.
    Ragusa F
    Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis and the Th1 chemokine MIG.
    Paparo SR
    Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIG in Cutaneous Systemic Lupus Erythematosus.
    Ruffilli I
    Clin Ter; 2019; 170(1):e71-e76. PubMed ID: 30789201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
    Knapp CM; He J; Lister J; Whitehead KA
    Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.
    Jinquan T; Jing C; Jacobi HH; Reimert CM; Millner A; Quan S; Hansen JB; Dissing S; Malling HJ; Skov PS; Poulsen LK
    J Immunol; 2000 Aug; 165(3):1548-56. PubMed ID: 10903763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
    BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.